Dementia Research

ETH Zurich Pins GRK2 Aggregation as Alzheimer’s Target and Reveals 'Compound 10' That Slows Decline in Mice

Preclinical results show the small molecule prevents GRK2 clumping, restores mitochondrial function and lowers amyloid‑beta while the lab seeks a commercial partner for development.